| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | presynapse | PDE4B CTTNBP2 SGIP1 ITSN1 RPS11 GRIA3 GRIP1 AP1S1 SEPTIN3 ATP6AP2 ARHGAP44 AP3B2 UNC13C RIMS1 DMD RIMS2 | 2.23e-05 | 886 | 113 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 5.36e-05 | 14 | 113 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | cell cortex region | 1.02e-04 | 45 | 113 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.18e-04 | 141 | 113 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.52e-04 | 23 | 113 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | centrosome | PDE4B CCDC18 CENPU CHD3 CHD4 ODF2 CCDC77 KMT2E CEP350 LIMK2 ERCC6L2 CAMSAP2 GEN1 | 2.68e-04 | 770 | 113 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 3.33e-04 | 61 | 113 | 4 | GO:0030660 | |
| GeneOntologyCellularComponent | dendritic spine | 3.48e-04 | 242 | 113 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 3.94e-04 | 247 | 113 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | presynaptic membrane | 7.77e-04 | 277 | 113 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 7.94e-04 | 8 | 113 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.04e-03 | 378 | 113 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | synaptic membrane | ITSN1 GRIA3 GRIP1 SEPTIN3 ATP6AP2 KCNJ4 UNC13C RIMS1 DMD RIMS2 | 1.25e-03 | 583 | 113 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | microtubule organizing center | PDE4B CCDC18 CENPU CHD3 CHD4 ODF2 CCDC77 KMT2E CEP350 LIMK2 ERCC6L2 CAMSAP2 GEN1 | 1.39e-03 | 919 | 113 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | neuron projection terminus | 1.69e-03 | 233 | 113 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | terminal bouton | 1.83e-03 | 96 | 113 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.14e-03 | 523 | 113 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 2.23e-03 | 48 | 113 | 3 | GO:0030119 | |
| Domain | Znf_FYVE_PHD | 2.05e-06 | 147 | 107 | 8 | IPR011011 | |
| Domain | PHD | 1.21e-05 | 89 | 107 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.38e-05 | 91 | 107 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.76e-05 | 95 | 107 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.87e-05 | 96 | 107 | 6 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 3.53e-05 | 65 | 107 | 5 | IPR019786 | |
| Domain | PHD | 7.05e-05 | 75 | 107 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 9.04e-05 | 79 | 107 | 5 | IPR019787 | |
| Domain | CHDCT2 | 9.72e-05 | 3 | 107 | 2 | PF08074 | |
| Domain | CHDNT | 9.72e-05 | 3 | 107 | 2 | PF08073 | |
| Domain | DUF1086 | 9.72e-05 | 3 | 107 | 2 | IPR009462 | |
| Domain | DUF1087 | 9.72e-05 | 3 | 107 | 2 | IPR009463 | |
| Domain | CHD_N | 9.72e-05 | 3 | 107 | 2 | IPR012958 | |
| Domain | CHD_C2 | 9.72e-05 | 3 | 107 | 2 | IPR012957 | |
| Domain | TF_GATA-2/3 | 9.72e-05 | 3 | 107 | 2 | IPR016374 | |
| Domain | DUF1087 | 9.72e-05 | 3 | 107 | 2 | PF06465 | |
| Domain | DUF1086 | 9.72e-05 | 3 | 107 | 2 | PF06461 | |
| Domain | DUF1087 | 9.72e-05 | 3 | 107 | 2 | SM01147 | |
| Domain | DUF1086 | 9.72e-05 | 3 | 107 | 2 | SM01146 | |
| Domain | HJURP_C | 1.94e-04 | 4 | 107 | 2 | IPR022102 | |
| Domain | HJURP_C | 1.94e-04 | 4 | 107 | 2 | PF12347 | |
| Domain | MADS_MEF2-like | 1.94e-04 | 4 | 107 | 2 | IPR033896 | |
| Domain | Hexokinase | 4.80e-04 | 6 | 107 | 2 | IPR001312 | |
| Domain | MADS | 4.80e-04 | 6 | 107 | 2 | SM00432 | |
| Domain | MADS_BOX_1 | 4.80e-04 | 6 | 107 | 2 | PS00350 | |
| Domain | SRF-TF | 4.80e-04 | 6 | 107 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 4.80e-04 | 6 | 107 | 2 | PS50066 | |
| Domain | AT_hook | 4.84e-04 | 27 | 107 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.84e-04 | 27 | 107 | 3 | IPR017956 | |
| Domain | TF_MADSbox | 6.70e-04 | 7 | 107 | 2 | IPR002100 | |
| Domain | SNF2_N | 8.03e-04 | 32 | 107 | 3 | IPR000330 | |
| Domain | SNF2_N | 8.03e-04 | 32 | 107 | 3 | PF00176 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.05e-03 | 35 | 107 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.33e-03 | 38 | 107 | 3 | PS00690 | |
| Domain | FYVE_2 | 1.73e-03 | 11 | 107 | 2 | PF02318 | |
| Domain | RABBD | 2.07e-03 | 12 | 107 | 2 | PS50916 | |
| Domain | ZnF_GATA | 2.07e-03 | 12 | 107 | 2 | SM00401 | |
| Domain | Rab_BD | 2.07e-03 | 12 | 107 | 2 | IPR010911 | |
| Domain | uDENN | 2.83e-03 | 14 | 107 | 2 | SM00800 | |
| Domain | Znf_GATA | 3.25e-03 | 15 | 107 | 2 | IPR000679 | |
| Domain | GATA | 3.25e-03 | 15 | 107 | 2 | PF00320 | |
| Domain | uDENN | 3.25e-03 | 15 | 107 | 2 | PF03456 | |
| Domain | UDENN | 3.70e-03 | 16 | 107 | 2 | PS50946 | |
| Domain | DDENN | 3.70e-03 | 16 | 107 | 2 | PS50947 | |
| Domain | GATA_ZN_FINGER_1 | 3.70e-03 | 16 | 107 | 2 | PS00344 | |
| Domain | DENN | 3.70e-03 | 16 | 107 | 2 | SM00799 | |
| Domain | dDENN | 3.70e-03 | 16 | 107 | 2 | SM00801 | |
| Domain | DENN | 3.70e-03 | 16 | 107 | 2 | PF02141 | |
| Domain | dDENN_dom | 3.70e-03 | 16 | 107 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.70e-03 | 16 | 107 | 2 | IPR005113 | |
| Domain | dDENN | 3.70e-03 | 16 | 107 | 2 | PF03455 | |
| Domain | DENN | 3.70e-03 | 16 | 107 | 2 | PS50211 | |
| Domain | DENN_dom | 3.70e-03 | 16 | 107 | 2 | IPR001194 | |
| Domain | GATA_ZN_FINGER_2 | 3.70e-03 | 16 | 107 | 2 | PS50114 | |
| Domain | 7TM_GPCR_Srsx | 3.94e-03 | 112 | 107 | 4 | SM01381 | |
| Domain | - | 4.30e-03 | 449 | 107 | 8 | 3.30.40.10 | |
| Domain | RUN | 4.69e-03 | 18 | 107 | 2 | SM00593 | |
| Domain | Znf_RING/FYVE/PHD | 4.90e-03 | 459 | 107 | 8 | IPR013083 | |
| Domain | RUN | 5.22e-03 | 19 | 107 | 2 | PS50826 | |
| Domain | RUN | 5.22e-03 | 19 | 107 | 2 | PF02759 | |
| Domain | Run_dom | 5.22e-03 | 19 | 107 | 2 | IPR004012 | |
| Pubmed | PDS5B RALB WBP11 ATP5PO ITSN1 TAF1B RPS11 ASH1L GRIA3 CHD3 CHD4 ODF2 CCDC77 CXorf65 ZC3H7A ZFR RIMS1 DMD PPIP5K2 RIMS2 CAMSAP2 CCDC158 RPL18 | 3.17e-10 | 1442 | 115 | 23 | 35575683 | |
| Pubmed | WBP11 PDE4B ARHGAP24 CTTNBP2 SGIP1 ITSN1 GRIA3 CHD4 SHTN1 AP1S1 SNW1 SEPTIN3 KCNJ4 ARHGAP44 ZFR RIMS1 CAMSAP2 SH3BP5 | 2.98e-09 | 963 | 115 | 18 | 28671696 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PDS5B RBM12B TAF1B CENPU ZCCHC17 CHD3 CHD4 RBM28 GTPBP1 PRC1 ZC3H7A SNW1 ZFR RBM34 RPL18 | 3.36e-08 | 759 | 115 | 15 | 35915203 |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 3.50e-07 | 5 | 115 | 3 | 34706221 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | WBP11 ATP5PO RPS11 CHD3 CHD4 RBM28 SNW1 BEND7 ZFR BRD1 RBM34 RPL18 | 8.34e-07 | 605 | 115 | 12 | 28977666 |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.22e-06 | 7 | 115 | 3 | 36398873 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 3.39e-06 | 361 | 115 | 9 | 30344098 | |
| Pubmed | 4.48e-06 | 128 | 115 | 6 | 30995482 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.66e-06 | 289 | 115 | 8 | 23752268 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 5.70e-06 | 11 | 115 | 3 | 34767769 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.08e-05 | 2 | 115 | 2 | 7560064 | |
| Pubmed | Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. | 1.08e-05 | 2 | 115 | 2 | 16469744 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25336633 | ||
| Pubmed | GATA motifs regulate early hematopoietic lineage-specific expression of the Gata2 gene. | 1.08e-05 | 2 | 115 | 2 | 16055713 | |
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 1.08e-05 | 2 | 115 | 2 | 25240052 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7575689 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22572823 | ||
| Pubmed | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. | 1.08e-05 | 2 | 115 | 2 | 21741404 | |
| Pubmed | GATA2-dependent and region-specific regulation of Gata2 transcription in the mouse midbrain. | 1.08e-05 | 2 | 115 | 2 | 19371385 | |
| Pubmed | Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses. | 1.08e-05 | 2 | 115 | 2 | 28701482 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17611778 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 38346193 | ||
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 1.08e-05 | 2 | 115 | 2 | 18794847 | |
| Pubmed | RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes. | 1.08e-05 | 2 | 115 | 2 | 29606581 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26400943 | ||
| Pubmed | The essential role of GATA transcription factors in adult murine prostate. | 1.08e-05 | 2 | 115 | 2 | 27374105 | |
| Pubmed | GATA3 is downregulated during hair cell differentiation in the mouse cochlea. | 1.08e-05 | 2 | 115 | 2 | 10447238 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19106099 | ||
| Pubmed | Functionally distinct Gata3/Chd4 complexes coordinately establish T helper 2 (Th2) cell identity. | 1.08e-05 | 2 | 115 | 2 | 23471993 | |
| Pubmed | A presynaptic phosphosignaling hub for lasting homeostatic plasticity. | 1.08e-05 | 2 | 115 | 2 | 35443170 | |
| Pubmed | Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression. | 1.08e-05 | 2 | 115 | 2 | 33299141 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15328158 | ||
| Pubmed | RIM genes differentially contribute to organizing presynaptic release sites. | 1.08e-05 | 2 | 115 | 2 | 22753485 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7720565 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 1.08e-05 | 2 | 115 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 1.08e-05 | 2 | 115 | 2 | 8843877 | |
| Pubmed | The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus. | 1.08e-05 | 2 | 115 | 2 | 22956829 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 1.78e-05 | 163 | 115 | 6 | 23333304 | |
| Pubmed | ASNSD1 WBP11 ATP5PO RPS11 GATA2 GATA3 CHD3 USP46 RBM28 GTPBP1 MEF2A MEF2C MYO5C SNW1 ZFR RBM34 | 1.97e-05 | 1429 | 115 | 16 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATP5PO RPS11 GATA2 CHD3 CHD4 RBM28 MAGT1 PRC1 SQOR AHDC1 CLASRP SNW1 HOXC10 ZFR RPL18 | 2.46e-05 | 1294 | 115 | 15 | 30804502 |
| Pubmed | Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function. | 2.77e-05 | 18 | 115 | 3 | 30833597 | |
| Pubmed | 3.24e-05 | 601 | 115 | 10 | 33658012 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 12041667 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 11792813 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27528231 | ||
| Pubmed | RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone. | 3.24e-05 | 3 | 115 | 2 | 21262468 | |
| Pubmed | GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia. | 3.24e-05 | 3 | 115 | 2 | 17654061 | |
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 3.24e-05 | 3 | 115 | 2 | 18093911 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 36806146 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26034270 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32070725 | ||
| Pubmed | Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. | 3.24e-05 | 3 | 115 | 2 | 18202227 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28377503 | ||
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 3.24e-05 | 3 | 115 | 2 | 22496871 | |
| Pubmed | RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. | 3.24e-05 | 3 | 115 | 2 | 21241895 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32658897 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 36251705 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27989458 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25343783 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 31486769 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32687248 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24043307 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28232602 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15834131 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25730884 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15330860 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26286136 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32220963 | ||
| Pubmed | Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex. | 3.24e-05 | 3 | 115 | 2 | 25155955 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 32483441 | ||
| Pubmed | Dynamic regulation of Gata factor levels is more important than their identity. | 3.24e-05 | 3 | 115 | 2 | 17327407 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 33315889 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B WBP11 ATP5PO RBM12B RPS11 CHD3 CHD4 RBM28 MYO5C CEP350 SNW1 ZFR RPL18 | 3.54e-05 | 1024 | 115 | 13 | 24711643 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PDE4B RPS11 USP46 BLZF1 MEF2A CLASRP CEP350 ZC3H7A AP1S1 DMD CAMSAP2 SH3BP5 RPL18 | 4.07e-05 | 1038 | 115 | 13 | 26673895 |
| Pubmed | 5.94e-05 | 23 | 115 | 3 | 35815619 | ||
| Pubmed | Protein composition of axonal dopamine release sites in the striatum. | 6.48e-05 | 4 | 115 | 2 | 36579890 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 22764880 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 8575763 | ||
| Pubmed | Divergent properties and independent regulation of striatal dopamine and GABA co-transmission. | 6.48e-05 | 4 | 115 | 2 | 35584679 | |
| Pubmed | RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. | 6.48e-05 | 4 | 115 | 2 | 21262469 | |
| Pubmed | Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. | 6.48e-05 | 4 | 115 | 2 | 10330143 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 15542836 | ||
| Pubmed | MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. | 6.48e-05 | 4 | 115 | 2 | 18079734 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 18849568 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 32562431 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 10207130 | ||
| Pubmed | Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. | 6.48e-05 | 4 | 115 | 2 | 8548800 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 15632071 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 21531906 | ||
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 6.48e-05 | 4 | 115 | 2 | 24591619 | |
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 6.48e-05 | 4 | 115 | 2 | 7643214 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 12620390 | ||
| Pubmed | The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4. | 6.48e-05 | 4 | 115 | 2 | 10556076 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16574654 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 11809751 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 15140898 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 9326634 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 25284784 | ||
| Pubmed | GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. | 6.48e-05 | 4 | 115 | 2 | 9043071 | |
| Pubmed | Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice. | 6.48e-05 | 4 | 115 | 2 | 19926876 | |
| Interaction | NDC80 interactions | ATP5PO CCDC18 CENPU ODF2 CCDC77 NSRP1 MYO5C CEP350 SNW1 CAMSAP2 | 1.22e-05 | 312 | 115 | 10 | int:NDC80 |
| Interaction | GNL2 interactions | WBP11 CENPU ZCCHC17 CHD3 CHD4 RBM28 MAGT1 PRC1 NSRP1 RBM34 RPL18 | 1.32e-05 | 386 | 115 | 11 | int:GNL2 |
| Interaction | NONO interactions | RALB PDE4B ARHGAP24 TAF1B CHD3 CHD4 PRC1 SQOR NSRP1 E2F8 MYO5C SNW1 CD274 | 1.53e-05 | 549 | 115 | 13 | int:NONO |
| Interaction | MAGEB2 interactions | 3.18e-05 | 349 | 115 | 10 | int:MAGEB2 | |
| GeneFamily | PHD finger proteins | 1.65e-05 | 90 | 64 | 5 | 88 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 7.37e-05 | 4 | 64 | 2 | 833 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 7.37e-05 | 4 | 64 | 2 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.23e-04 | 5 | 64 | 2 | 1086 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.96e-04 | 12 | 64 | 2 | 1305 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 8.73e-04 | 53 | 64 | 3 | 103 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.26e-03 | 15 | 64 | 2 | 82 | |
| GeneFamily | PDZ domain containing | 2.06e-03 | 152 | 64 | 4 | 1220 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.51e-03 | 25 | 64 | 2 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.43e-03 | 34 | 64 | 2 | 487 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RALB PDE4B ARHGAP24 CTTNBP2 SGIP1 KDM4C ACOX1 ITSN1 ASH1L GATA3 USP46 H6PD MEF2C ZFR PPIP5K2 SH3BP5 | 8.13e-07 | 854 | 113 | 16 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RALB PDE4B ARHGAP24 CTTNBP2 SGIP1 KDM4C ACOX1 ITSN1 ASH1L GATA3 USP46 H6PD MEF2C ZFR PPIP5K2 SH3BP5 | 1.35e-06 | 888 | 113 | 16 | MM1018 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ACOX1 ITSN1 ASH1L GATA2 GATA3 IFI44 GRIA3 KMT2E MEF2A MYO5C PTPRK SPON1 BEX4 DMD | 2.79e-06 | 721 | 113 | 14 | M1999 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B GNE KDM4C ITSN1 AHDC1 MEF2A CEP350 ATP2C1 SNW1 PTPRK DENND5A DMD PPIP5K2 CAMSAP2 CCDC93 | 4.18e-06 | 856 | 113 | 15 | M4500 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.10e-05 | 193 | 113 | 7 | M6813 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.32e-05 | 196 | 113 | 7 | MM667 | |
| ToppCell | severe-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-08 | 200 | 115 | 8 | 6d0ac3d00400dd5657ee266f7b885381bf790ce1 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-08 | 200 | 115 | 8 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.15e-07 | 184 | 115 | 7 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-07 | 191 | 115 | 7 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-07 | 191 | 115 | 7 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 6.62e-07 | 191 | 115 | 7 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | B_cell_maturation-Naive_B_cell|World / Lineage and Cell class | 6.86e-07 | 192 | 115 | 7 | 58267a11c938a380c6e26f4e4ce63f3b4be79fdc | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_intermediate|COVID-19_Severe / Disease group, lineage and cell class | 7.10e-07 | 193 | 115 | 7 | ea079e6f7242a2bbc8260299ad9e9bdabb9856f8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.10e-07 | 193 | 115 | 7 | b5e44fe60dc84dc050d4fa3ccec4e257e51dc636 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.10e-07 | 193 | 115 | 7 | e2cf2f4f142e1b4dda3ded28b5208eef3f301a43 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.35e-07 | 194 | 115 | 7 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.35e-07 | 194 | 115 | 7 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | COVID-19_Severe-B_intermediate|COVID-19_Severe / disease group, cell group and cell class | 7.35e-07 | 194 | 115 | 7 | 3418308da7f1278ae2bf3fb61fc361b222e30043 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.35e-07 | 194 | 115 | 7 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.72e-07 | 199 | 115 | 7 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 8.72e-07 | 199 | 115 | 7 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate|COVID-19_Severe / Disease, condition lineage and cell class | 8.72e-07 | 199 | 115 | 7 | ad3c369a67926725917b771094f82ca6dd2af783 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.02e-07 | 200 | 115 | 7 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 137 | 115 | 6 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 137 | 115 | 6 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 4.19e-06 | 163 | 115 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-06 | 169 | 115 | 6 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-06 | 173 | 115 | 6 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-06 | 173 | 115 | 6 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-06 | 173 | 115 | 6 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 176 | 115 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 176 | 115 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-06 | 185 | 115 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-06 | 186 | 115 | 6 | 664295cd508dc3894d55da7e9d9cd75bf1432f52 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-06 | 186 | 115 | 6 | b30eb0c1673ca1ebc9b6248877d86fd6d6d14470 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.92e-06 | 186 | 115 | 6 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.48e-06 | 188 | 115 | 6 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.48e-06 | 188 | 115 | 6 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.77e-06 | 189 | 115 | 6 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 190 | 115 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.07e-05 | 192 | 115 | 6 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 192 | 115 | 6 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.07e-05 | 192 | 115 | 6 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-05 | 192 | 115 | 6 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-05 | 193 | 115 | 6 | 7cc10e8b51091869d46e462f3214999e7b5348b1 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.10e-05 | 193 | 115 | 6 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.10e-05 | 193 | 115 | 6 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | Healthy_donor-B_intermediate|Healthy_donor / disease group, cell group and cell class (v2) | 1.10e-05 | 193 | 115 | 6 | e2be57bf3cbbbbff64853f06b9c11b136f73eea7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 194 | 115 | 6 | 7f62bd52779e2779447b23bdd330be4b5b35910a | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 1.13e-05 | 194 | 115 | 6 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 1.13e-05 | 194 | 115 | 6 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | B_cell_maturation-Naive_B_cell|B_cell_maturation / Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | adb6f9aff65276e0db1f8367149998938b8e4fb0 | |
| ToppCell | Healthy/Control-B_intermediate|Healthy/Control / Disease group and Cell class | 1.13e-05 | 194 | 115 | 6 | 8a4260eeccb4924c392798b1ffa23cdd3a4062e9 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 195 | 115 | 6 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-05 | 195 | 115 | 6 | dd28c63b53f2a97e3fac127294a465870dc371b3 | |
| ToppCell | Healthy/Control-B_naive|Healthy/Control / Disease group and Cell class | 1.20e-05 | 196 | 115 | 6 | e92d2c814d2dcb049f3e455fe66fd40898b3524d | |
| ToppCell | Healthy_donor-B_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.20e-05 | 196 | 115 | 6 | cf254b1466357984201595fa32408d659eb741ef | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-Subcortical|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-05 | 196 | 115 | 6 | bf8fe28193348342987d361c8e8b9e1d6d542678 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.20e-05 | 196 | 115 | 6 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.24e-05 | 197 | 115 | 6 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 197 | 115 | 6 | a97556e9fbb24272de51f54ecda6ab9ccb97a61e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.24e-05 | 197 | 115 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 1.24e-05 | 197 | 115 | 6 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | mild_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 1.24e-05 | 197 | 115 | 6 | b817ecdcea453a15fd0dd1d7fdf196bed68f7358 | |
| ToppCell | severe-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-05 | 198 | 115 | 6 | 88649dc642193bda5e8eff3f79c832807d5e200a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 198 | 115 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 198 | 115 | 6 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-05 | 199 | 115 | 6 | 38747e07853f60d11eda9371cf5e6493e21a9cc3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | (09)_Ionocytes|World / shred by cell type and Timepoint | 2.66e-05 | 135 | 115 | 5 | 237b9b646513ca6e4b754c0da95d24015b3661f7 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.98e-05 | 160 | 115 | 5 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 6.34e-05 | 162 | 115 | 5 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 164 | 115 | 5 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 164 | 115 | 5 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 164 | 115 | 5 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.12e-05 | 166 | 115 | 5 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.33e-05 | 167 | 115 | 5 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-05 | 168 | 115 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-05 | 168 | 115 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | Ionocyte|World / Class top | 7.97e-05 | 170 | 115 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 170 | 115 | 5 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 170 | 115 | 5 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.65e-05 | 173 | 115 | 5 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 8.65e-05 | 173 | 115 | 5 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.65e-05 | 173 | 115 | 5 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 174 | 115 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 174 | 115 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 174 | 115 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.89e-05 | 174 | 115 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-05 | 174 | 115 | 5 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 9.13e-05 | 175 | 115 | 5 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; HL60; HT_HG-U133A | 6.63e-07 | 195 | 115 | 9 | 1867_DN | |
| Disease | Inherited acute myeloid leukemia | 8.22e-05 | 4 | 110 | 2 | C4707228 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.69e-04 | 152 | 110 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.14e-04 | 93 | 110 | 4 | C1535926 | |
| Disease | mean reticulocyte volume | 8.23e-04 | 799 | 110 | 10 | EFO_0010701 | |
| Disease | TPE interval measurement | 9.75e-04 | 52 | 110 | 3 | EFO_0004644 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 1.22e-03 | 14 | 110 | 2 | EFO_0004708 | |
| Disease | disease free survival | 2.03e-03 | 18 | 110 | 2 | EFO_0000409 | |
| Disease | Petit mal status | 2.03e-03 | 67 | 110 | 3 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 2.03e-03 | 67 | 110 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.03e-03 | 67 | 110 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.03e-03 | 67 | 110 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.03e-03 | 67 | 110 | 3 | C0751523 | |
| Disease | Complex Partial Status Epilepticus | 2.03e-03 | 67 | 110 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.12e-03 | 68 | 110 | 3 | C0038220 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 2.50e-03 | 20 | 110 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.80e-03 | 75 | 110 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 3.00e-03 | 261 | 110 | 5 | C0004352 | |
| Disease | Hodgkin Disease | 3.03e-03 | 22 | 110 | 2 | C0019829 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 3.60e-03 | 24 | 110 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PETRQQKKKARMSKM | 56 | P0DKL9 | |
| DKLKMMEGRNSSIRK | 1016 | O95696 | |
| GQLMKTIIRKINKMK | 976 | Q9NR48 | |
| QEAIIQIMKMRKKIS | 716 | Q93034 | |
| RRSKQAQMKVEKMRK | 286 | Q96LI9 | |
| LERRRIQMLKMKEAK | 116 | A6NEN9 | |
| ERFVGQMMEIKRKTR | 81 | Q9NWD9 | |
| MGRMRQLEKKLKRAI | 191 | O60239 | |
| KKIKRSSIRKGMVMV | 466 | O00178 | |
| KERKKMVRELMQVVL | 26 | P61966 | |
| RTNKMGKRLQIMTKR | 391 | Q9BR77 | |
| NAKMISDIEKKRQRM | 306 | Q71F23 | |
| KRTTKNLEAGVMKEM | 231 | P35368 | |
| KLSRKMRKEMNVLTE | 1571 | P11532 | |
| GKCRGVRRMVVKMAK | 466 | Q5TGY3 | |
| GVMRMVKKRAIVKKL | 321 | P98194 | |
| MSVKTKIQKLGRAMR | 196 | P48047 | |
| EAMKRIVAMIARGKN | 56 | Q13367 | |
| KAEMQKTIEMKRTDR | 76 | Q8IXT5 | |
| DLMREIRTKKMSENK | 171 | P11234 | |
| LKGMNMKEIKGRTVA | 171 | Q9NW13 | |
| KMKELRIQRSLQKMR | 586 | Q9NW13 | |
| MALEGMSKRKRKRSV | 1 | P42696 | |
| LRKGRMMDVKKCGIQ | 261 | Q9NZQ7 | |
| ISKEEMVRRLKMVVK | 26 | Q9NTI5 | |
| RMEKKIQREREMEKG | 121 | Q9H0G5 | |
| RKKKRAVIMMVTVVA | 266 | Q96P65 | |
| GITMMRKKAKFSLRE | 366 | Q96P65 | |
| KKVMRRMQKEMDRGL | 31 | P35557 | |
| MVKKLVMAQKRGETR | 1 | Q16558 | |
| IMAKMARPKKRAQTL | 171 | P48050 | |
| RKKEMVLSEKVSQLM | 31 | Q9H0U3 | |
| QRTMKMKQRDKKVVT | 206 | A8MVJ9 | |
| GKMLTEKAMEVKAVR | 66 | Q9H2G9 | |
| KATGKVMVMKELIRC | 351 | P53671 | |
| KMEMPKQTRHRKLKV | 141 | Q86SG4 | |
| MARQKKMGQSVLRAV | 1 | P42263 | |
| KQRQTLRKMVIDMVL | 501 | Q07343 | |
| RKDMVKISMDIFVRK | 311 | Q9H3R0 | |
| KRKMTREERKMEAIL | 571 | Q8IZD2 | |
| FTKVEMKEKMLRAAR | 221 | Q9UN81 | |
| MKEKMLRAAREKGRV | 226 | Q9UN81 | |
| MGRKKIQITRIMDER | 1 | Q06413 | |
| MLKKMGEAVARVARK | 1 | Q8TCA0 | |
| MGRKKIQITRIMDER | 1 | Q02078 | |
| RNKDVKKAMMKVISR | 291 | Q8NGP4 | |
| AVLMRKAKREKVETM | 481 | Q86UR5 | |
| AVRKTKREKMETMLR | 496 | Q9UQ26 | |
| EVKQMRARRKTAKML | 286 | O43613 | |
| RPRATVMVMVKGVNK | 71 | O75787 | |
| RKKFTMIEIKMRNAE | 691 | Q8N264 | |
| LTMKKEGIQTRNRKM | 386 | P23769 | |
| MKKEGIQTRNRKMSS | 356 | P23771 | |
| EVAVRKSAIMVKKMR | 61 | Q15067 | |
| KSAIMVKKMREFGIA | 66 | Q15067 | |
| IVEGIKQSRMKMEKK | 566 | Q567U6 | |
| IDGRNRKVIMDLKTM | 116 | Q8TCB0 | |
| RAKVQPQARKKEMEM | 436 | P15169 | |
| RKDKSLRVMSQKFVM | 261 | A0AVK6 | |
| AGSKEMVRVMRKKGI | 256 | Q9Y223 | |
| RRLLQTMDMIISKKK | 191 | B7ZAQ6 | |
| RRLLQTMDMIISKKK | 191 | P0CG08 | |
| KEKLRIMAVKNSEVM | 316 | Q5T9S5 | |
| KMRKMIEQLKRGSDS | 261 | Q8WZ74 | |
| EERITQVAKRKMMLT | 1191 | Q12873 | |
| LKALRVRKKMSGEKM | 1296 | Q15811 | |
| MRDDIRVMTQVVKKA | 411 | Q4G0X9 | |
| KLEMVMGKVREEAKR | 891 | Q86WZ0 | |
| QKMMKFGRKKRDRVD | 3046 | Q5VT06 | |
| VEGLLKECRMKTKRM | 736 | Q6ZUT9 | |
| KTKRMLVEKMGREAV | 761 | Q6IQ26 | |
| MKLKKMNRENRIREL | 321 | Q9NYD6 | |
| KRAMQFGSRIAKMEK | 601 | Q9NWL6 | |
| VDMQTTRKILMKKSV | 781 | Q17RS7 | |
| ESMEIKKQITGMRRL | 51 | Q8N7W2 | |
| MVKSLERENIRKMQG | 16 | Q96C01 | |
| GKNDRVKAMDMKRIK | 3661 | Q8NDH2 | |
| MLRKVVEELTAKKMT | 476 | Q5M9N0 | |
| LATGRKAMQRLAKKM | 361 | Q5T890 | |
| GTMMRRRLKKKDFKS | 436 | Q9Y3R0 | |
| SVTLRKMKQEIKEIM | 981 | Q9Y3R0 | |
| INRAKKVAVLVMGRM | 736 | O95479 | |
| EERITQVAKKKMMLT | 1181 | Q14839 | |
| IDQMLRVKGMKHRKT | 521 | O76082 | |
| KMEAAFTKQRQKMGR | 781 | Q08AD1 | |
| KKRKDAMGNTRQEMT | 781 | Q15262 | |
| VKMQKGERQMAKRFL | 141 | Q5BJF6 | |
| VVTKMKMQRTIVIRR | 76 | P62280 | |
| QRKRSERKITLMVMM | 261 | P30872 | |
| KGKRMRQRMLKAQLD | 461 | Q9HCB6 | |
| ITMAARMKRKVGAEN | 56 | Q9Y6N5 | |
| RKEKGIVKMTMPQTL | 201 | Q53T94 | |
| VIMGARRKAMRKYAK | 566 | P58743 | |
| RQMRDKNRKPVVMKI | 121 | Q9Y227 | |
| KRKVMRMLKRQVSVS | 316 | P32249 | |
| KMQNMKKVIEAIRVE | 286 | O43663 | |
| KRQAVEEMMDRIKKG | 406 | A0MZ66 | |
| KDGLRKIQSMGVRVM | 506 | Q17R89 | |
| MVKTRMQLEQKVRGS | 151 | Q9BSK2 | |
| MQFRKVSKGMEAKVI | 396 | Q16280 | |
| KLRGMMVDYKKRAER | 11 | Q8N2M8 | |
| MKNDRIKVSLSMKVV | 76 | Q9NP64 | |
| MIRKMKLPGRENKTA | 66 | Q07020 | |
| TIITAMKERMKIREK | 1166 | Q8NB66 | |
| MMEGLKKRTRKAFGI | 1 | Q9BQI5 | |
| TIIEQMRKKTMKTGF | 46 | Q9UH03 | |
| RKVMQFMGKKVDETV | 206 | O00338 | |
| RGMKSLVNKMTVALK | 481 | Q9NUY8 | |
| GLKTQRMKALRMLVK | 306 | A2RTY3 | |
| GAKQRVIRMVEMQKD | 191 | Q13573 | |
| VIRVQKRHKMPRMKK | 256 | Q96A28 | |
| KDRRAMRVMSIERKK | 741 | Q8IWR0 | |
| QEAQKRMRVKKLPMI | 236 | P62068 | |
| IRARKIQEEKMRKQM | 626 | Q96KR1 | |
| VIRHGDRTPKQKMKM | 386 | O43314 | |
| KKNKKQRMMVRAAVL | 31 | Q9Y2W2 | |
| KMTKMKRALFVKERR | 2096 | Q6ZQQ6 | |
| RKKMTRITPTMKELQ | 71 | Q13522 | |
| ISLRMKHGRVNMQKK | 6 | Q96CX3 | |
| KEGMMELRRKTKSRE | 801 | A6NCI4 | |
| RGITAERKAMMQQKV | 831 | Q8N1T3 | |
| KREMREKMSEITKQL | 1096 | Q9NQX4 |